"がん治療" の関連情報検索結果

Our Q1 2026 financial results - Merck.com



Our Q1 2026 financial results  Merck.com

FDA issues warning letter to ImmunityBio over misleading promotion of NAI - Urology Times



FDA issues warning letter to ImmunityBio over misleading promotion of NAI  Urology Times

Myriad Genetics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance



Myriad Genetics, Inc. Q1 2026 Earnings Call Summary  Yahoo Finance

Head & Neck Cancer Therapeutics Market Size, Share [2034] - Fortune Business Insights



Head & Neck Cancer Therapeutics Market Size, Share [2034]  Fortune Business Insights

Recursion Q1 2026 slides: pipeline advances amid revenue shortfall - Investing.com



Recursion Q1 2026 slides: pipeline advances amid revenue shortfall  Investing.com

Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer - Investor's Business Daily



Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer  Investor's Business Daily

Iran Unveils Nuclear Ointment for Skin Cancer Treatment - WANA News Agency



Iran Unveils Nuclear Ointment for Skin Cancer Treatment  WANA News Agency

Ivermectin, from the Capitol to state-funded cancer research — it’s a thing in Florida - Florida ...



Ivermectin, from the Capitol to state-funded cancer research — it’s a thing in Florida  Florida Politics

From the Prostate Cancer Research Desk: Immunotherapy Combination Shows Promise in Prostate Cance...



From the Prostate Cancer Research Desk: Immunotherapy Combination Shows Promise in Prostate Cancer  Prostate Cancer Foundation (PCF)

Esophageal Cancer Therapeutics Market Size, Share [2034] - Fortune Business Insights



Esophageal Cancer Therapeutics Market Size, Share [2034]  Fortune Business Insights

Dr Yongyut Kongthanarat - Radiation Oncologist - MedPark Hospital



Dr Yongyut Kongthanarat - Radiation Oncologist  MedPark Hospital

Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop - Nature



Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop  Nature

CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers - National Cancer Institut...



CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers  National Cancer Institute (.gov)

FDA Gives Fast Track Status to SIM0505 in Platinum-Resistant Ovarian Cancer - CancerNetwork



FDA Gives Fast Track Status to SIM0505 in Platinum-Resistant Ovarian Cancer  CancerNetwork

Patriots DC Terrell Williams declared cancer-free following battle with prostate cancer - NFL.com



Patriots DC Terrell Williams declared cancer-free following battle with prostate cancer  NFL.com

Future Energy: Think about Nuclear Energy: Hitachi : Hitachi - Hitachi Global



Future Energy: Think about Nuclear Energy: Hitachi : Hitachi  Hitachi Global

Keanu Reeves' 3 Sisters: All About Kim, Karina and Emma - People.com



Keanu Reeves' 3 Sisters: All About Kim, Karina and Emma  People.com

Dynamic cancer transcriptome exposes new therapeutic targets - Nature



Dynamic cancer transcriptome exposes new therapeutic targets  Nature

Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line - Nature



Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line  Nature

Quadruplex nucleic acids as targets for anticancer therapeutics - Nature



Quadruplex nucleic acids as targets for anticancer therapeutics  Nature

IAEA Ramps Up Commitment to Advance Development and Cancer Care Across Africa - International Ato...



IAEA Ramps Up Commitment to Advance Development and Cancer Care Across Africa  International Atomic Energy Agency

Pancreatic Cancer Treatment Market Size, Share | Growth [2034] - Fortune Business Insights



Pancreatic Cancer Treatment Market Size, Share | Growth [2034]  Fortune Business Insights

Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects - Yahoo Finance



Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects  Yahoo Finance

AstraZeneca Records 22 Percent Growth in Q4 Oncology Business as Precision Drug Sales Surge - Pre...



AstraZeneca Records 22 Percent Growth in Q4 Oncology Business as Precision Drug Sales Surge  Precision Medicine Online

Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity - Yahoo Finance



Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity  Yahoo Finance

Pfizer Posts Better-Than-Expected Revenue, Profit - WSJ



Pfizer Posts Better-Than-Expected Revenue, Profit  WSJ

FDA Approves Atezolizumab Plus Bevacizumab for Liver Cancer - National Cancer Institute (.gov)



FDA Approves Atezolizumab Plus Bevacizumab for Liver Cancer  National Cancer Institute (.gov)

Towards Improved Cancer Treatment: IAEA and Okayama University to Cooperate in Boron Neutron Capt...



Towards Improved Cancer Treatment: IAEA and Okayama University to Cooperate in Boron Neutron Capture Therapy R&D  International Atomic Energy Agency

Dietary intervention as a therapeutic for cancer - Morita - 2021 - Cancer Science - Wiley Online ...



Dietary intervention as a therapeutic for cancer - Morita - 2021 - Cancer Science  Wiley Online Library

PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachex...



PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features  Wiley Online Library

Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer thera...



Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy  Nature

J&J says 2026 sales could top $100 billion - pharmaphorum



J&J says 2026 sales could top $100 billion  pharmaphorum

Ancient ‘Pharaoh’s Curse’ Might Be the Future of Cancer Treatment - VICE



Ancient ‘Pharaoh’s Curse’ Might Be the Future of Cancer Treatment  VICE

Cameron Mathison Shows Off Scars from His 'Scary' Battle with Kidney Cancer: 'There Was Such a La...



Cameron Mathison Shows Off Scars from His 'Scary' Battle with Kidney Cancer: 'There Was Such a Lack of Control'  People.com

Reframing ImmunityBio: The Long-Term Platform Opportunity Beyond Anktiva (NASDAQ:IBRX) - Seeking ...



Reframing ImmunityBio: The Long-Term Platform Opportunity Beyond Anktiva (NASDAQ:IBRX)  Seeking Alpha

Metastatic Castration-Resistant Prostate Cancer Therapeutics Market KEY TAKEAWAYS - Fortune Busin...



Metastatic Castration-Resistant Prostate Cancer Therapeutics Market KEY TAKEAWAYS  Fortune Business Insights

Houston immunotherapy company to use $13.5M grant to further develop cancer treatments - Innovati...



Houston immunotherapy company to use $13.5M grant to further develop cancer treatments  InnovationMap

IBM’s Watson Hasn’t Beaten Cancer, But A.I. Still Has Promise - Bloomberg.com



IBM’s Watson Hasn’t Beaten Cancer, But A.I. Still Has Promise  Bloomberg.com

Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery' - Sk...



Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery'  Sky News

癌治療のための音楽 - YouTube



癌治療のための音楽  YouTube

Daraxonrasib presentation receives a standing ovation at ASCO|Taro Watanabe - note



Daraxonrasib presentation receives a standing ovation at ASCO|Taro Watanabe  note

米女優シャナン・ドハーティ、乳がんで治療中=ピープル誌 - Reuters



米女優シャナン・ドハーティ、乳がんで治療中=ピープル誌  Reuters

Contributing to cancer treatment by tumor-selective toxicity - academist (アカデミスト)



Contributing to cancer treatment by tumor-selective toxicity  academist (アカデミスト)

テロメラーゼ逆転写酵素が これまで知られていなかった機序でがん化を促進することを発見 ―肉腫を含むが...



テロメラーゼ逆転写酵素が これまで知られていなかった機序でがん化を促進することを発見 ―肉腫を含むがんの新たな治療法の開発に期待  金沢大学

Message from Anna Umemiya: “I began treatment for breast cancer on July 31.” - OTONA SALONE



Message from Anna Umemiya: “I began treatment for breast cancer on July 31.”  OTONA SALONE

英チャールズ国王 DJ体験 機材触れる姿が話題に - EDM MAXX



英チャールズ国王 DJ体験 機材触れる姿が話題に  EDM MAXX

Ryuichi Hirota received “Dean’s Award of the Graduate School of Engineering, Tohoku University”! ...



Ryuichi Hirota received “Dean’s Award of the Graduate School of Engineering, Tohoku University”!  tohoku.ac.jp

A Tale of Two Cancers: The Short, Full Lives of Kobayashi Mao and Kuroki Nana - Unseen Japan



A Tale of Two Cancers: The Short, Full Lives of Kobayashi Mao and Kuroki Nana  Unseen Japan